Latvia vs Middle income: Immunization, Hib3
Latvia
97.0%
in 2024
Middle income
77.1%
in 2024
Latvia rank
29th
Middle income rank
26th
Immunization, Hib3 over time
- Latvia
- Middle income
How they compare
Latvia currently reports 97.0% against 77.1% in Middle income, a difference of 19.9%.
That makes Latvia's figure about 1.3 times Middle income's.
Across all 31 years both countries report, Latvia has been ahead every year.
Latvia ranks 29th and Middle income ranks 26th of 191 countries.
Latvia has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Latvia | Middle income | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 48.8% | 0.4% | 48.4% | Latvia |
| 2000s | 92.1% | 14.2% | 77.9% | Latvia |
| 2010s | 94.2% | 52.3% | 41.9% | Latvia |
| 2020s | 96.4% | 73.4% | 23.0% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Latvia or Middle income?
- Latvia, at 97.0% against 77.1% in Middle income as of 2024.
- What is the difference in immunization, hib3 between Latvia and Middle income?
- 19.9%, with Latvia ahead.
- How many years of comparable data are there for Latvia and Middle income?
- 31 years are reported by both, from 1994 to 2024.
- How do Latvia and Middle income rank globally for immunization, hib3?
- Latvia ranks 29th and Middle income ranks 26th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.